Danaher Corporation $DHR Shares Purchased by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC raised its position in Danaher Corporation (NYSE:DHR) by 22.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 95,443 shares of the conglomerate’s stock after buying an additional 17,478 shares during the period. Mutual of America Capital Management LLC’s holdings in Danaher were worth $18,923,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in DHR. Sivia Capital Partners LLC lifted its stake in Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares in the last quarter. Perigon Wealth Management LLC raised its holdings in Danaher by 1.3% in the 2nd quarter. Perigon Wealth Management LLC now owns 4,643 shares of the conglomerate’s stock valued at $917,000 after buying an additional 61 shares during the period. Kathmere Capital Management LLC boosted its stake in Danaher by 13.8% during the second quarter. Kathmere Capital Management LLC now owns 1,272 shares of the conglomerate’s stock worth $251,000 after buying an additional 154 shares during the period. Patton Fund Management Inc. acquired a new stake in shares of Danaher during the second quarter valued at about $221,000. Finally, LVW Advisors LLC acquired a new stake in shares of Danaher during the second quarter valued at about $211,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 21,776 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Teri List sold 3,298 shares of the company’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 30,248 shares of company stock worth $6,609,663. 11.20% of the stock is owned by insiders.

Danaher Stock Performance

Shares of Danaher stock opened at $234.91 on Monday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The firm’s 50 day moving average is $230.26 and its two-hundred day moving average is $213.26. The firm has a market capitalization of $165.93 billion, a P/E ratio of 48.43, a P/E/G ratio of 3.58 and a beta of 0.89.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Morgan Stanley began coverage on Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price target for the company. Leerink Partners raised their target price on Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a report on Friday, January 16th. HSBC boosted their price target on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Monday, December 1st. Argus set a $265.00 price target on shares of Danaher in a research report on Wednesday, January 14th. Finally, Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday, October 8th. Twenty investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.09.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.